The North West London Acute Provider Group (APG), comprising Imperial College Healthcare NHS Trust, Chelsea and Westminster Hospital NHS Foundation Trust, London North West University Healthcare NHS Trust and The Hillingdon Hospitals NHS Foundation Trust, is preparing to undertake a procurement exercise for an Ambient Voice Technology (AVT) solution.
As part of our preliminary market engagement process, we are inviting suppliers to participate in a supplier engagement event to help shape our procurement strategy and ensure that our requirements are realistic, deliverable and aligned to current market capabilities.
Please refer to the engagement pack for further details.
Atamis notice ref. C471397
NWLP and SWLP Pre-market engagement for a Pathology IT LIMS system
North West London Pathology & South West London Pathology are jointly seeking to understand market capacity and supplier capability in relation to a future procurement for a Pathology IT Laboratory Information Management System (LIMS) solution and associated implementation, migration, integration, training and support services. The purpose of this early market engagement is to inform the Authority on available market solutions, delivery approaches, implementation risks, commercial models, and opportunities to further strengthen NWLP’s and SWLP's pathology operating model.
Both NWLP and SWLP’s current state demonstrates a thriving, high-performing pathology network, but also one operating at scale and under continued transformation. The networks have highlighted sustained testing growth, increasing operational complexity, ongoing investment in digital pathology and automation, and the need for resilient infrastructure, strong interoperability beyond the traditional HL7 messaging and future-proofed digital capability. Both NWLP and SWLP laboratories support large-scale hub and spoke operations, urgent and routine testing pathways, a wide range of specialist diagnostics, and extensive GP and community connectivity.
A future of an Interoperable LIMS procurement is therefore anticipated to support both NWLP and SWLP in maintaining clinical safety, standardisation, regulatory compliance, operational performance while enabling further digital transformation and leveraging artificial intelligence and machine learning to support the future delivery of pathology and diagnostic services. Both NWLP and SWLP wishes to understand how the market can support disciplines including biochemistry, haematology, blood transfusion, microbiology, immunology, H&I, virology, cellular pathology, andrology, genetics and molecular workflows; provide robust interfaces into EPRs, national systems, automation platforms and analytics tools; and deliver a scalable platform aligned with NWLP and SWLP’s strategic direction.
Suppliers who are interested in this opportunity should complete the attached questionnaire and respond back by 1st October 2026 at 12 noon. To access the opportunity, please use Atamis via contract reference C467704
https://atamis-1928--prospend.vf.force.com/apex/CS_ContractPage?filters=&page=1&Preview=Yes&searchStr=&SearchType=Projects&sortStr=Alphabetical&uid=a07Pz00001e3fTKIAY&sfdcIFrameOrigin=https%3A%2F%2Fatamis-1928.lightning.force.com
